Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTBVAC vs BCG in Healthy Adolescents and Adults
NCT06997367Phase 2Active, not recruiting
- Sponsor
- Bharat Biotech
- Start
- Mar 2025
- Primary completion
- Sep 2025
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of mtbvac in Tuberculosis (TB), sponsored by Bharat Biotech. Started Mar 2025; status: active, not recruiting.
02
Drugs
mtbvac
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT06997367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06997367.